Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Juli 2023

Genmab — Juli 2023

Planlagt Fastgjort Låst Flyttet Genmab
551 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • P Offline
    P Offline
    ProinvestorNEWS
    wrote on sidst redigeret af
    #158

    J&J again boosts full-year outlook as Darzalex https://firstwordpharma.com/story/5762723

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #159

      J&J's Darzalex stays on its upward trajectory as company adds $1B to annual sales projection https://www.fiercepharma.com/pharma/johnson-johnsons-darzalex-continues-its-upward-trajectory-company-boosts-2023-revenue

      1 Reply Last reply
      0
      • J Offline
        J Offline
        JKY_VH
        wrote on sidst redigeret af
        #160

        Ved ikke om denne har været nævnt"Genmab (+1,9%, 2769) har fået hævet kursmålet for sin ADR-notering i USA til 45 dollar fra 43 dollar af BMO Capital, der fastholder den neutrale anbefaling "market perform". Torsdag lukkede ADR-noteringen i kurs 41,45 dollar efter en stigning på 1,3 pct. Der går ti ADR-aktier på én dansk. "

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gdn55
          wrote on sidst redigeret af
          #161

          Svarer til godt 3000 d.kr

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #162

            Genmab Announces AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL) https://ir.genmab.com/news-releases/news-release-details/genmab-announces-abbvie-receives-positive-chmp-opinion

            1 Reply Last reply
            0
            • D Offline
              D Offline
              deleted-user
              wrote on sidst redigeret af
              #163

              Har administrator slettet i dagens chat?

              1 Reply Last reply
              0
              • Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktørH Offline
                Helge_LarsenPI-redaktør
                wrote on sidst redigeret af
                #164

                Næ..Hvorfor det?

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #165

                  Syns blot jeg læste to indlæg om udtalelse fra CHMP, men jeg skal måske forbi Louis Nielsen. Tak

                  1 Reply Last reply
                  0
                  • P Offline
                    P Offline
                    ProinvestorNEWS
                    wrote on sidst redigeret af
                    #166

                    Ok. Det var mit eget som var magen til det fra E L . Derfor blev det slettet.

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #167

                      Vi postede i samme sekund. Opdagede først fejlen lidt senere.

                      1 Reply Last reply
                      0
                      • D Offline
                        D Offline
                        deleted-user
                        wrote on sidst redigeret af
                        #168

                        Det kan næppe være en fejl 🙂

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          deleted-user
                          wrote on sidst redigeret af
                          #169

                          Janssen Receives Positive CHMP Opinions for Novel Bispecific Antibodies TALVEY®▼ (talquetamab) and TECVAYLI®▼ https://www.jnj.com/janssen-receives-positive-chmp-opinions-for-novel-bispecific-antibodies-talvey-talquetamab-and-tecvayli-teclistamab-for-the-treatment-of-patients-with-relapsed-and-refractory-multiple-myeloma

                          1 Reply Last reply
                          0
                          • E Offline
                            E Offline
                            E_L
                            wrote on sidst redigeret af
                            #170

                            I specially waited so we didn't post it twice 😉

                            1 Reply Last reply
                            0
                            • E Offline
                              E Offline
                              E_L
                              wrote on sidst redigeret af
                              #171

                              But 2 genmab antibodies in 1 day...

                              1 Reply Last reply
                              0
                              • E Offline
                                E Offline
                                E_L
                                wrote on sidst redigeret af
                                #172

                                And both a bit earlier as expected

                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #173

                                  3?

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #174

                                    I was not counting tecvayli as it is really just a different dosing regime, but please feel free to celebrate 3 🙂

                                    1 Reply Last reply
                                    0
                                    • BulderB Offline
                                      BulderB Offline
                                      Bulder
                                      wrote on sidst redigeret af
                                      #175

                                      Nu er genmab steget 9 handelsdage i træk. Øjner vi en tendens til at pendulet er ved at svinge tilbage mod defensive medicinal? Hvis det er tilfældet, venter et par muntre uger.

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #176

                                        https://twitter.com/MAWildgust/status/1682371273903558657?t=c8nbW12gzO3CwrRL6idelQ&s=19

                                        1 Reply Last reply
                                        0
                                        • BulderB Offline
                                          BulderB Offline
                                          Bulder
                                          wrote on sidst redigeret af
                                          #177

                                          S&P500 healthcare er steget pænt siden 7/7. https://www.spglobal.com/spdji/en/indices/equity/sp-500-health-care-sector/

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper